AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

Go back to AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

AVITA Medical, Inc. (RCEL) Tops Q4 EPS by 3c

February 23, 2023 4:36 PM EST

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q4 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $9.46 million versus the consensus estimate of $8.8 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

... More